article thumbnail

Temporal Trends in Noninvasive and Invasive Cardiac Testing From 2010 to 2022 in the US Medicare Population

Circulation: Cardiovascular Imaging

Circulation: Cardiovascular Imaging, Ahead of Print. in 2022, followed by single-photon emission computed tomography (CT) myocardial perfusion imaging, which decreased from 20.8% in 2022, followed by single-photon emission computed tomography (CT) myocardial perfusion imaging, which decreased from 20.8% to 12.9%.

article thumbnail

The Evolution of Cardiovascular Magnetic Resonance: A 50-Year Journey

Cardiology Update

These foundational advancements set the stage for Lauterbur and Mansfield’s work in the 1970s, which integrated proton-resonant frequency differences to produce images reflective of tissue characteristics. The third stage, beginning in 2010 and continuing today, emphasized the widespread clinical use of CMR.

article thumbnail

The Evolving Computed Tomography Market

DAIC

According to an abstract issued by the Journal of Cardiovascular Computed Tomography (JCCT), cardiac CT continues to expand with increasing applications and evolving technology. It reported the rate of CCTA exams by radiologists in hospital outpatient departments increased markedly from 2010 to 2019. Reeves, MD, Ethan J.

article thumbnail

Utility of Left and Right Ventricular Strain in Arrhythmogenic Right Ventricular Cardiomyopathy: A Prospective Multicenter Registry

Circulation: Cardiovascular Imaging

Circulation: Cardiovascular Imaging, Volume 16, Issue 12 , Page e015671, December 1, 2023. ARVC prevalence by 2010 ARVC Revised Task Force Criteria is 91/109 (83%) and 83/99 (84%) in those with RV strain measurements. BACKGROUND:Imaging evaluation of arrhythmogenic right ventricular cardiomyopathy (ARVC) remains challenging.

article thumbnail

Longitudinal Assessment of Subclinical Arterial Inflammation in Patients Receiving Immune Checkpoint Inhibitors by Sequential [18F]FDG PET Scans

Circulation: Cardiovascular Imaging

Circulation: Cardiovascular Imaging, Ahead of Print. BACKGROUND:Immune checkpoint inhibitors (ICIs), though revolutionary in cancer treatment, may accelerate atherosclerosis by inducing arterial inflammation. Patients aged 65 years with at least 4 sequential scans within 30 months were included.

Cancer 40